Healthcare AI and digital health leader strengthens the team driving innovation in evidence generation.

DURHAM, N.C.: #Appointments--Target RWE, a leader in advancing modern evidence generation for complex clinical and regulatory challenges, announced the appointment of Sriram Krishnan, Ph.D. as the company’s new Chief Product Officer. A recognized leader in healthcare AI and digital health, Krishnan joins the company with decades of experience in building and commercializing products with patient impact.

“Sriram’s proven success in applying advanced technologies to improve patient outcomes aligns perfectly with our mission and makes him the ideal individual to lead our product team,” said Ed Seguine, Chief Executive Officer of Target RWE. “As Target RWE continues to expand our real-world evidence and data-driven research capabilities, Sriram’s deep expertise and passion for leveraging technology to improve the delivery of care will be invaluable.”

Prior to joining Target RWE, Krishnan served as Executive Vice President of Products at ConcertAI, where he built and scaled a global organization focused on real-world data, advanced analytics, and AI-driven clinical and commercial solutions. Most recently, Krishnan was Chief Product Officer at Carenostics, an early-stage company developing AI-driven clinical decision support tools for chronic disease management, which was recognized as a “Rising Star in AI” at HLTH. During his career, he has also held senior leadership roles at Siemens Healthineers, KPMG, and Deloitte.

Dr. Krishnan holds 28 issued patents and has authored more than 30 scientific publications spanning machine learning and digital health. He received his Ph.D. in Biomedical Engineering from the University of Michigan.

“I am thrilled to join Target RWE at this important inflection point in the company’s evolution,” said Sriram Krishnan, Target RWE, Chief Product Officer. “Target RWE is at the forefront of applying new approaches to generate real world evidence that can meet the demands of today’s rapidly changing healthcare system. I am honored to join a team of such talented individuals dedicated to translating data into insights for the betterment of patient care.”

About Target RWE

Target RWE generates real-world evidence (RWE) that informs strategic decisions across the drug development lifecycle. Our unique combination of clinical, analytical and technical expertise enables comprehensive insight generation from complete retrospective and prospective longitudinal patient journeys, with unparalleled scale and accuracy.

Visit our website to learn more: https://targetrwe.com/

Fonte: Business Wire